Impact of Transarterial Chemoembolization or Hepatic Artery Infusion Chemotherapy on Liver Function after Hepatocellular Carcinoma Resection: An Observational Study

被引:3
|
作者
Yue, Rongbin [1 ]
Liu, Xiqiang [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 5, Div Hepatol, Zhuhai, Peoples R China
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Hepatic artery infusion chemotherapy; Liver function; Postoperation; POSTOPERATIVE TACE; TUMOR THROMBUS; FAILURE; 5-FLUOROURACIL; PROGNOSIS; MRI; HCC;
D O I
10.1159/000528750
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Liver surgery leads to a high degree of heterogeneity in the prognosis of hepatocellular carcinoma (HCC) patients. However, most previous studies focused on the postoperative therapeutic effects of other treatments, with relatively few studies on the impacts on liver function. This study investigated the impact of transarterial chemoembolization (TACE) and hepatic artery infusion chemotherapy (HAIC) on liver function after HCC resection from various angles. Methods: 138 HCC patients were enrolled, including 27 patients who received TACE and 80 patients who received HAIC. Besides routine treatment such as liver protection and antiviral therapy, 31 patients received no other treatment. The different groups were compared with various biological parameters with four types of scoring methods. Results: In the short term after TACE, the mean (+/- SD) alanine transaminase and aspartate transaminase values increased by 79.22 +/- 117.43 U/L and 66.33 +/- 94.54 U/L, respectively (p < 0.01). The mean (+/- SD) total bilirubin (TBIL) values increased by 4.02 +/- 6.08 mu mol/L (p < 0.01). The mean (+/- SD) albumin (ALB) values decreased by 3.54 +/- 2.93 g/L (p < 0.001). The mean (+/- SD) albumin bilirubin (ALBI) scores increased by 0.39 +/- 0.22 (p < 0.001). In the short term after HAIC, the mean (+/- SD) TBIL values increased by 2.11 +/- 5.57 mu mol/L (p < 0.01). The mean (+/- SD) ALB values decreased by 2.52 +/- 3.26 g/L (p < 0.001), and the mean (+/- SD) ALBI scores increased by 0.21 +/- 0.42 (p < 0.001). In both treatment groups, the long-term liver function was not significantly different from that before treatment and also from that of the untreated group (p > 0.05). Conclusion: TACE after HCC resection has a significant impact on short-term liver function, whereas HAIC has a relatively small impact, but neither has a major impact on long-term liver function.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 50 条
  • [42] Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
    Houseni, Mohamed
    Hady, Mahmoud Abdel Aziz Abdel
    Abokoura, Sameh
    EGYPTIAN LIVER JOURNAL, 2023, 13 (01)
  • [43] Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
    Mohamed Houseni
    Mahmoud Abdel Aziz Abdel Hady
    Sameh Abokoura
    Egyptian Liver Journal, 13
  • [44] Comparison of liver injury after transcatheter arterial chemoembolization and hepatic arterial infusion chemotherapy for intermediate and advanced hepatocellular carcinoma
    Li, R.
    Li, W.
    Yuan, G.
    Li, Q.
    Hu, X.
    Zhu, P.
    Chen, Y.
    Su, K.
    Guo, Y.
    Zang, M.
    Chen, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1552 - S1552
  • [45] Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study
    Deng, Min
    Cai, Hao
    He, Benyi
    Guan, Renguo
    Lee, Carol
    Guo, Rongping
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (11) : 3303 - 3311
  • [46] Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis
    Si, Tengfei
    Huang, Zhenlin
    Khorsandi, Shirin Elizabeth
    Ma, Yun
    Heaton, Nigel
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [47] Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma
    Baojiang Liu
    Xu Zhu
    Song Gao
    Jianhai Guo
    Xiaodong Wang
    Guang Cao
    Linzhong Zhu
    Peng Liu
    Haifeng Xu
    Hui Chen
    Xin Zhang
    Shaoxing Liu
    Fuxin Kou
    Journal of Interventional Medicine, 2019, 2 (02) : 91 - 96
  • [48] Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis
    Department of Inflammation Biology, Faculty of Life Sciences Medicine, Institute of Liver Studies, King’s College Hospital, King’s College London, Denmark Hill, London, United Kingdom
    不详
    不详
    不详
    Front. Bioeng. Biotechnol., 2022,
  • [49] Results of hepatocellular carcinoma downstaging through hepatic transarterial chemoembolization in liver transplantation
    de Morais, Beatriz G.
    Horbe, Alex F.
    Coral, Gabriela Perdomo
    Jotz, Raquel de F.
    Fontana, Priscila C.
    Mattos, Angelo A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (01) : 77 - 82
  • [50] Comparison of Hepatic Arterial Infusion Chemotherapy and Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Liu, Haonan
    Qin, Xiaobing
    Jiang, Hong
    Sun, Chenyu
    Wu, Meng
    Xu, Zhiyuan
    Lu, Tong
    Ma, Xiao
    Han, Zhengxiang
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022, 31 (03) : 336 - 343